loading...| Preferred Name |
Mupirocin |
|
| Synonyms |
MUPIROCIN Mupirocin |
|
| Definitions |
A natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29271 |
|
| CAS_Registry |
12650-69-0 |
|
| Chemical_Formula |
C26H44O9 |
|
| code |
C29271 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A natural crotonic acid derivative extracted from Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by specific reversible binding to bacterial isoleucyl tRNA synthase. With excellent activity against gram-positive staphylococci and streptococci, it is primarily used for treatment of primary and secondary skin disorders, nasal infections, and wound healing. (NCI04) |
|
| FDA_UNII_Code |
D0GX863OA5 |
|
| FULL_SYN |
MUPIROCIN Mupirocin |
|
| Has_Salt_Form | ||
| label |
Mupirocin |
|
| Legacy Concept Name |
Mupirocin |
|
| Preferred_Name |
Mupirocin |
|
| prefixIRI |
Thesaurus:C29271 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0085259 |
|
| subClassOf |